Predictors for readmission following primary total hip and total knee arthroplasty.


Journal

Journal of orthopaedic surgery (Hong Kong)
ISSN: 2309-4990
Titre abrégé: J Orthop Surg (Hong Kong)
Pays: England
ID NLM: 9440382

Informations de publication

Date de publication:
Historique:
entrez: 6 10 2020
pubmed: 7 10 2020
medline: 13 4 2021
Statut: ppublish

Résumé

Readmission following total joint arthroplasty has become a closely watched metric for many hospitals in the United States due to financial penalties imposed by Centers for Medicare and Medicaid Services. The purpose of this study was to identify both preoperative and postoperative reasons for readmission within 30 days following primary total hip and total knee arthroplasty (TKA). Retrospective data were collected for patients who underwent elective primary total hip arthroplasty (THA; CPT code 27130) and TKA (27447) from 2008 to 2013 at our institution. The sample was separated into readmitted and nonreadmitted cohorts. Demography, comorbidities, Charlson comorbidity index (CCI), operative parameters, readmission rates, and causes of readmission were compared between the groups using univariate and multivariate regression analysis. There were 42 (3.4%) and 28 (2.2%) readmissions within 30 days for THA and TKA, respectively. The most common cause of readmission within 30 days following total joint arthroplasty was infection. Trauma was the second most common reason for readmission of a THA while wound dehiscence was the second most common cause for readmission following TKA. With univariate regression, there were multiple associated factors for readmission among THA and TKA patients, including body mass index, metabolic equivalent (MET), and CCI. Multivariate regression revealed that hospital length of stay was significantly associated with 30-day readmission after THA and TKA. Patient comorbidities and preoperative functional capacity significantly affect 30-day readmission rate following total joint arthroplasty. Adjustments for these parameters should be considered and we recommend the use of CCI and METs in risk adjustment models that use 30-day readmission as a marker for quality of patient care. Level III/Retrospective cohort study.

Sections du résumé

BACKGROUND
Readmission following total joint arthroplasty has become a closely watched metric for many hospitals in the United States due to financial penalties imposed by Centers for Medicare and Medicaid Services. The purpose of this study was to identify both preoperative and postoperative reasons for readmission within 30 days following primary total hip and total knee arthroplasty (TKA).
METHODS
Retrospective data were collected for patients who underwent elective primary total hip arthroplasty (THA; CPT code 27130) and TKA (27447) from 2008 to 2013 at our institution. The sample was separated into readmitted and nonreadmitted cohorts. Demography, comorbidities, Charlson comorbidity index (CCI), operative parameters, readmission rates, and causes of readmission were compared between the groups using univariate and multivariate regression analysis.
RESULTS
There were 42 (3.4%) and 28 (2.2%) readmissions within 30 days for THA and TKA, respectively. The most common cause of readmission within 30 days following total joint arthroplasty was infection. Trauma was the second most common reason for readmission of a THA while wound dehiscence was the second most common cause for readmission following TKA. With univariate regression, there were multiple associated factors for readmission among THA and TKA patients, including body mass index, metabolic equivalent (MET), and CCI. Multivariate regression revealed that hospital length of stay was significantly associated with 30-day readmission after THA and TKA.
CONCLUSION
Patient comorbidities and preoperative functional capacity significantly affect 30-day readmission rate following total joint arthroplasty. Adjustments for these parameters should be considered and we recommend the use of CCI and METs in risk adjustment models that use 30-day readmission as a marker for quality of patient care.
LEVEL OF EVIDENCE
Level III/Retrospective cohort study.

Identifiants

pubmed: 33021145
doi: 10.1177/2309499020959160
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2309499020959160

Auteurs

Ong-Art Phruetthiphat (OA)

Department of Orthopaedics, 37680Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.

Jesse E Otero (JE)

Department of Orthopaedic Surgery and Rehabilitation, 21782University of Iowa Hospital and Clinics, Iowa City, IA, USA.

Biagio Zampogna (B)

Department of Orthopaedics and Trauma Surgery, 9317University Campus Bio-Medico of Rome, Rome, Italy.

Sebastiano Vasta (S)

Department of Orthopaedics and Trauma Surgery, 9317University Campus Bio-Medico of Rome, Rome, Italy.

Yubo Gao (Y)

Department of Orthopaedic Surgery and Rehabilitation, 21782University of Iowa Hospital and Clinics, Iowa City, IA, USA.

John J Callaghan (JJ)

Department of Orthopaedic Surgery and Rehabilitation, 21782University of Iowa Hospital and Clinics, Iowa City, IA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH